These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11565049)

  • 1. [Marker transport across biological barriers in vitro: comparison of cell culture models for the gastrointestinal barrier, the blood-brain barrier and the alveolar epithelium of the lung].
    Gindorf C; Steimer A; Lehr CM; Bock U; Schmitz S; Haltner E
    ALTEX; 2001; 18(3):155-64. PubMed ID: 11565049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of cell culture models for the intestine and the blood-brain barrier and comparison of drug permeation.
    Bock U; Flötotto T; Haltner E
    ALTEX; 2004; 21 Suppl 3():57-64. PubMed ID: 15057409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro models of intestinal and alveolar epithelium cultures in pharmaceutical research].
    Lehr CM
    ALTEX; 2001; 18(1):59-63. PubMed ID: 11248854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to assess drug permeability across the blood-brain barrier.
    Nicolazzo JA; Charman SA; Charman WN
    J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminum.
    Toimela T; Mäenpää H; Mannerström M; Tähti H
    Toxicol Appl Pharmacol; 2004 Feb; 195(1):73-82. PubMed ID: 14962507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro models for the blood-brain barrier.
    Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
    Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modern drug development by molecular- and cell-biological methods].
    Döhmer J
    ALTEX; 2001; 18(1):9-12. PubMed ID: 11248843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell culture-based models for intestinal permeability: a critique.
    Balimane PV; Chong S
    Drug Discov Today; 2005 Mar; 10(5):335-43. PubMed ID: 15749282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current in vitro and in silico models of blood-brain barrier penetration: a practical view.
    Vastag M; Keseru GM
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):115-24. PubMed ID: 19152220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening.
    Culot M; Lundquist S; Vanuxeem D; Nion S; Landry C; Delplace Y; Dehouck MP; Berezowski V; Fenart L; Cecchelli R
    Toxicol In Vitro; 2008 Apr; 22(3):799-811. PubMed ID: 18280105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro permeability studies as a substitute for in vivo studies--which requirements have to be met?].
    Haltner E; Schmitz S; Gindorf C; Ruoff J
    ALTEX; 2001; 18(1):81-7. PubMed ID: 11248857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary combinatorial chemistry, a novel tool for SAR studies on peptide transport across the blood-brain barrier. Part 2. Design, synthesis and evaluation of a first generation of peptides.
    Teixidó M; Belda I; Zurita E; Llorà X; Fabre M; Vilaró S; Albericio F; Giralt E
    J Pept Sci; 2005 Dec; 11(12):789-804. PubMed ID: 15942930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in vitro cell models in predicting in vivo brain entry of drugs.
    Hakkarainen JJ; Jalkanen AJ; Kääriäinen TM; Keski-Rahkonen P; Venäläinen T; Hokkanen J; Mönkkönen J; Suhonen M; Forsberg MM
    Int J Pharm; 2010 Dec; 402(1-2):27-36. PubMed ID: 20920560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs.
    van Bree JB; de Boer AG; Danhof M; Ginsel LA; Breimer DD
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1233-9. PubMed ID: 3204515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
    Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
    Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C.
    Fuchs S; Hollins AJ; Laue M; Schaefer UF; Roemer K; Gumbleton M; Lehr CM
    Cell Tissue Res; 2003 Jan; 311(1):31-45. PubMed ID: 12483282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell culture models of the respiratory tract relevant to pulmonary drug delivery.
    Steimer A; Haltner E; Lehr CM
    J Aerosol Med; 2005; 18(2):137-82. PubMed ID: 15966771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
    Flaten GE; Dhanikula AB; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro.
    Reichl S
    J Pharm Pharmacol; 2008 Mar; 60(3):299-307. PubMed ID: 18284809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity.
    Fagerholm U
    Drug Discov Today; 2007 Dec; 12(23-24):1076-82. PubMed ID: 18061888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.